Join the Fasenra group to help and get support from people like you.
Fasenra News
FDA Adds Fasenra Indication for Severe Asthma in Children
TUESDAY, April 16, 2024 – The U.S. Food and Drug Administration has approved an additional indication for Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years...
Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma
WILMINGTON, Del.--(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients wi...
Benralizumab Noninferior to Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis
FRIDAY, March 8, 2024 – For patients with eosinophilic granulomatosis with polyangiitis (EGPA) receiving standard care, benralizumab is noninferior to mepolizumab, according to a study published in...
Tapering of Inhaled Steroids Feasible for Asthma Controlled With Benralizumab
WEDNESDAY, Jan. 10, 2024 – For patients with severe eosinophilic asthma controlled on benralizumab, tapering of inhaled corticosteroids (ICS) is feasible and is not associated with worse asthma...
Many Primary Care Docs Unaware of Biologic Asthma Meds
TUESDAY, Nov. 21, 2023 – Biologic drugs to treat asthma have been around for two decades, but a surprising number of family doctors still aren’t prescribing them to kids and adults. A new survey f...
FDA Approves Fasenra Pen (benralizumab) Pre-Filled Auto-Injector for Self-Administration
October 4, 2019 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector...
FDA Approves Fasenra (benralizumab) for Severe Eosinophilic Asthma
November 14, 2017 – AstraZeneca (NYSE:AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra...
Ask a question
To post your own question to this support group, sign in or create an account.